| Stage | NCI | % of rev | LULU | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $223M | 100.00% | $2.4B | 100.00% | LULU ×10.83 |
| Gross profit | $56M | 25.18% | $1.5B | 60.52% | LULU +35.3pp |
| Operating income | $15M | 6.52% | $454M | 18.78% | LULU +12.3pp |
| Pre-tax income | $15M | 6.55% | $467M | 19.35% | LULU +12.8pp |
| Net income | $11M | 5.13% | $329M | 13.63% | LULU +8.5pp |
| Stage | NCI | LULU | Gap · A − B |
|---|---|---|---|
| Revenue | $223M100.00% | $2.4B100.00% | LULU ×10.83 |
| Gross profit | 25.18%$56M | 60.52%$1.5B | LULU +35.3pp |
| Operating income | 6.52%$15M | 18.78%$454M | LULU +12.3pp |
| Pre-tax income | 6.55%$15M | 19.35%$467M | LULU +12.8pp |
| Net income |
| 5.13%$11M |
| 13.63%$329M |
| LULU +8.5pp |
None
No disclosed counterparties: NCI.